Highlights bioMérieux

Equities

Real-time Euronext Paris Other stock markets 15:45:26 16/09/2024 BST			5-day change	1st Jan Change
108.30 ^EUR	-1.63%		-1.81%	+7.65%

09-09	The market burns its idols
09-06	BIOMÉRIEUX : Invest Securities raises its target	CF

BioMérieux S.A. Reports Earnings Results for the Half Year Ended June 30, 2024	09-05	CI
BIOMERIEUX : Q2 beat + guidance upgrade hailed by the markets	09-05
BIOMÉRIEUX : Oddo BHF confirms its recommendation	09-05	CF
BioMérieux raises its targets for 2024	09-05	CF
Market Update-Europe closes higher on optimism about US rates	07-04	RE
BioMérieux Announces USDA-FSIS Field Service Laboratories Selects GENE-UP Pathogenic E. coli Assay as Primary Method for Shiga Toxin-Producing E. coli Detection	07-02	CI
Ex-dividend day for final dividend	06-06	FA
BioMérieux, Pfizer to Collaborate on Antimicrobial Resistance Initiative in Malawi	05-23	MT
BioMérieux S.A. acquired assets from Ares Genetics GmbH.	04-28	CI
BIOMÉRIEUX : Berenberg raises its target	04-26	CF
BIOMÉRIEUX : Stifel raises target price	04-10	CF
BIOMÉRIEUX : Oddo BHF raises its target price	04-10	CF
BIOMÉRIEUX : Invest Securities raises its target	04-10	CF
BIOMERIEUX : A strong start to 2024	04-09
BioMérieux: hailed for its business review and targets	04-09	CF
BioMérieux: targets set for 2024-28	04-09	CF
BioMérieux: growth of over 6% in Q1	04-09	CF
BioMérieux: food safety initiative	04-05	CF
BIOMERIEUX : Good end to 2023; routine testing dynamics remain intact	03-14
BioMérieux S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI

No results for this search

BIOMERIEUX : Q2 beat + guidance upgrade hailed by the markets

September 05, 2024 at 02:34 pm